Dentsply Sirona Affirms FY2026 Adj EPS Guidance of $1.40-$1.50 vs $1.43 Est; Affirms FY2026 Sales Guidance of $3.500B-$3.600B vs $3.578B Est

Benzinga Newsdesk www.benzinga.com Neutral 55.5%

Neg 0% Neu 55.5% Pos 0%

Dentsply Sirona (NASDAQ:XRAY) affirms FY2026 Adj EPS guidance from $1.40-$1.50 to $1.40-$1.50 vs $1.43 analyst estimate. Affirms FY2026 sales outlook from $3.500 billion-$3.600 billion to $3.500 billion-$3.600 billion vs $3.578 billion estimate.